Kun Zhang
Directeur/Membre du Conseil chez SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Fortune : 3 M $ au 30/04/2024
Postes actifs de Kun Zhang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Directeur/Membre du Conseil | 20/04/2018 | - |
| Corporate Officer/Principal | 20/04/2018 | - |
Historique de carrière de Kun Zhang
Anciens postes connus de Kun Zhang
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Essen Technology (Beijing) Co., Ltd.
 Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/11/2014 | 01/10/2020 |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Sales & Marketing | 01/05/2009 | 01/01/2011 |
| MICROPORT SCIENTIFIC CORPORATION | Sales & Marketing | 01/05/2002 | 01/03/2004 |
Formation de Kun Zhang
| Academy of Armored Forces Engineering | Undergraduate Degree |
| City University of Hong Kong | Masters Business Admin |
Statistiques
Internationale
| Chine | 5 |
| Îles Cayman | 2 |
| Hong Kong | 2 |
Opérationnelle
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| MICROPORT SCIENTIFIC CORPORATION | Health Technology |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
| Entreprise privées | 1 |
|---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Health Technology |
